Fedratinib dihydrochloride hydrate
| CAS No. | 1374744-69-0 | Cat. No. | BCP24783 |
| Name | Fedratinib dihydrochloride hydrate | ||
| Synonyms | TG-101348 hydrochloride hydrate; SAR 302503 hydrochloride hydrate;SAR302503; SAR-302503; SAR 302503; TG101348; TG-101348; TG 101348; | ||
| Formula | C27H40Cl2N6O4S | M. Wt | 615.62 |
| Description | Fedratinib hydrochloride hydrate is a potent, selective, ATP-competitive and orally active JAK2 inhibitor with IC50s of 3 nM for both JAK2 and JAK2V617F kinase. Fedratinib hydrochloride hydrate shows 35- and 334-fold selectivity over JAK1 and JAK3, respectively. Fedratinib hydrochloride hydrate induces cancer cell apoptosis and has the potential for myeloproliferative disorders research. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase Jak/Stat Pathway Wnt/Stem Cell Epigenetics | ||
| Targets | JAK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.